Patent · US Active

Crystalline form of rabeprazole sodium

US8143409B2 · kind B2 · utility

0Cited by

10References

5Claims

0Family size

Assignee

DIPHARMA FRANCIS S.R.L. · IT

Inventors

Giuseppe Barreca · Milano, IT
Alessandro Restelli · Baranzate, IT
Pietro Allegrini · Baranzate, IT

Key dates

Filing date	Dec 18, 2007
Grant date	Mar 27, 2012
Priority date	—
Expiry date	Nov 2, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P1/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Rabeprazole sodium in the monohydrate crystalline form, pharmaceutical compositions thereof, the use thereof in therapy, a process for its preparation, and the use thereof for the purification of rabeprazole sodium.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.